The CXCR4/SDF1 axis improves muscle regeneration through MMP-10 activity

Stem Cells and Development

Volumn 23, Issue 12, 2014, Pages 1417-1427

  Bobadilla, Miriam ^a   Sainz, Neira ^a   Abizanda, Gloria ^a   Orbe, Josune ^a   Rodriguez, José Antonio ^a   Páramo, José Antonio ^a   Prósper, Felipe ^a,b   Pérez Ruiz, Ana ^a  

^a UNIVERSITY OF NAVARRA   (Spain)

^b UNIVERSITY CLINIC OF NAVARRA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; LIGAND; NOTEXIN; PLERIXAFOR; SMALL INTERFERING RNA; STROMAL CELL DERIVED FACTOR 1; STROMELYSIN 2; CXCR4 PROTEIN, MOUSE; HETEROCYCLIC COMPOUND; SNAKE VENOM;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; ENZYME ACTIVITY; EXPERIMENTAL MODEL; IN VITRO STUDY; MOUSE; MUSCLE DEVELOPMENT; MUSCLE INJURY; MUSCLE REGENERATION; MYOBLAST; NONHUMAN; PRIORITY JOURNAL; RNA INTERFERENCE; SKELETAL MUSCLE; SKELETAL MUSCLE SATELLITE CELL; TISSUE REPAIR; UPREGULATION; AGONISTS; ANIMAL; CELL MOTION; CELL PROLIFERATION; DRUG EFFECTS; GENETICS; HUMAN; METABOLISM; REGENERATION; SIGNAL TRANSDUCTION; TOXICITY;

ANIMALS; CELL MOVEMENT; CELL PROLIFERATION; CHEMOKINE CXCL12; ELAPID VENOMS; HETEROCYCLIC COMPOUNDS; HUMANS; MATRIX METALLOPROTEINASE 10; MICE; MUSCLE DEVELOPMENT; MUSCLE, SKELETAL; RECEPTORS, CXCR4; REGENERATION; SIGNAL TRANSDUCTION;

EID: 84902170610     PISSN: 15473287     EISSN: 15578534     Source Type: Journal    
DOI: 10.1089/scd.2013.0491     Document Type: Article

References (65)

1. Mauro A. (1961). Satellite cell of skeletal muscle fibers. J Biophys Biochem Cytol 9:493-495.
2. Moss FP and CP Leblond. (1971). Satellite cells as the source of nuclei in muscles of growing rats. Anat Rec 170:421-435.
3. Collins CA, I Olsen, PS Zammit, L Heslop, A Petrie, TA Partridge and JE Morgan. (2005). Stem cell function, selfrenewal, and behavioral heterogeneity of cells from the adult muscle satellite cell niche. Cell 122:289-301.
4. Charge SB and MA Rudnicki. (2004). Cellular and molecular regulation of muscle regeneration. Physiol Rev 84:209-238.
5. Hughes SM and HM Blau. (1990). Migration of myoblasts across basal lamina during skeletal muscle development. Nature 345:350-353.
6. Broxmeyer HE. (2001). Regulation of hematopoiesis by chemokine family members. Int J Hematol 74:9-17.
7. Nagasawa T, T Nakajima, K Tachibana, H Iizasa, CC Bleul, O Yoshie, K Matsushima, N Yoshida, TA Springer and T Kishimoto. (1996). Molecular cloning and characterization of a murine pre-B-cell growth-stimulating factor/ stromal cell-derived factor 1 receptor, a murine homolog of the human immunodeficiency virus 1 entry coreceptor fusin. Proc Natl Acad Sci U S A 93:14726-14729.
8. Lapidot T, A Dar and O Kollet. (2005). How do stem cells find their way home? Blood 106:1901-1910.
9. Wang K, X Zhao, C Kuang, D Qian, H Wang, H Jiang, M Deng and L Huang. (2012). Overexpression of SDF-1alpha enhanced migration and engraftment of cardiac stem cells and reduced infarcted size via CXCR4/PI3K pathway. PLoS One 7:e43922.
10. Percherancier Y, YA Berchiche, I Slight, R Volkmer-Engert, H Tamamura, N Fujii, M Bouvier and N Heveker. (2005). Bioluminescence resonance energy transfer reveals ligand-induced conformational changes in CXCR4 homoand heterodimers. J Biol Chem 280:9895-9903.
11. Sharma M, F Afrin, N Satija, RP Tripathi and GU Gangenahalli. (2011). Stromal-derived factor-1/CXCR4 signaling: indispensable role in homing and engraftment of hematopoietic stem cells in bone marrow. Stem Cells Dev 20:933-946.
12. Kucia M, K Jankowski, R Reca, M Wysoczynski, L Bandura, DJ Allendorf, J Zhang, J Ratajczak and MZ Ratajczak. (2004). CXCR4-SDF-1 signalling, locomotion, chemotaxis and adhesion. J Mol Histol 35:233-245.
13. Wong D and W Korz. (2008). Translating an antagonist of chemokine receptor CXCR4: from bench to bedside. Clin Cancer Res 14:7975-7980.
14. Broxmeyer HE, S Cooper, L Kohli, G Hangoc, Y Lee, C Mantel, DW Clapp and CH Kim. (2003). Transgenic expression of stromal cell-derived factor-1/CXC chemokine ligand 12 enhances myeloid progenitor cell survival/ antiapoptosis in vitro in response to growth factor withdrawal and enhances myelopoiesis in vivo. J Immunol 170:421-429.
15. Lataillade JJ, D Clay, P Bourin, F Herodin, C Dupuy, C Jasmin and MC Le Bousse-Kerdiles. (2002). Stromal cellderived factor 1 regulates primitive hematopoiesis by suppressing apoptosis and by promoting G(0)/G(1) transition in CD34( + ) cells: evidence for an autocrine/paracrine mechanism. Blood 99:1117-1129.
16. Konoplyannikov M, KH Haider, VK Lai, RP Ahmed, S Jiang and M Ashraf. (2013). Activation of diverse signaling pathways by ex-vivo delivery of multiple cytokines for myocardial repair. Stem Cells Dev 22:204-215.
17. Askari AT, S Unzek, ZB Popovic, CK Goldman, F Forudi, M Kiedrowski, A Rovner, SG Ellis, JD Thomas, et al. (2003). Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy. Lancet 362:697-703.
18. Hu X, S Dai, WJ Wu, W Tan, X Zhu, J Mu, Y Guo, R Bolli and G Rokosh. (2007). Stromal cell derived factor-1 alpha confers protection against myocardial ischemia/reperfusion injury: role of the cardiac stromal cell derived factor-1 alpha CXCR4 axis. Circulation 116:654-663.
19. Schober A. (2008). Chemokines in vascular dysfunction and remodeling. Arterioscler Thromb Vasc Biol 28:1950-1959.
20. Ho TK, J Tsui, S Xu, P Leoni, DJ Abraham and DM Baker. (2012). Angiogenic effects of stromal cell-derived factor-1 (SDF-1/CXCL12) variants in vitro and the in vivo expressions of CXCL12 variants and CXCR4 in human critical leg ischemia. J Vasc Surg 51:689-699.
21. Toupadakis CA, A Wong, DC Genetos, DJ Chung, D Murugesh, MJ Anderson, GG Loots, BA Christiansen, AS Kapatkin and CE Yellowley. (2012). Long-term administration of AMD3100, an antagonist of SDF-1/CXCR4 signaling, alters fracture repair. J Orthop Res 30:1853-1859.
22. Libura J, J Drukala, M Majka, O Tomescu, JM Navenot, M Kucia, L Marquez, SC Peiper, FG Barr, A Janowska-Wieczorek and MZ Ratajczak. (2002). CXCR4-SDF-1 signaling is active in rhabdomyosarcoma cells and regulates locomotion, chemotaxis, and adhesion. Blood 100: 2597-2606.
23. Fernandis AZ, A Prasad, H Band, R Klosel and RK Ganju. (2004). Regulation of CXCR4-mediated chemotaxis and chemoinvasion of breast cancer cells. Oncogene 23:157-167.
24. Ratajczak MZ, M Majka, M Kucia, J Drukala, Z Pietrzkowski, S Peiper and A Janowska-Wieczorek. (2003). Expression of functional CXCR4 by muscle satellite cells and secretion of SDF-1 by muscle-derived fibroblasts is associated with the presence of both muscle progenitors in bone marrow and hematopoietic stem/progenitor cells in muscles. Stem Cells 21:363-371.
25. Vasyutina E, J Stebler, B Brand-Saberi, S Schulz, E Raz and C Birchmeier. (2005). CXCR4 and Gab1 cooperate to control the development of migrating muscle progenitor cells. Genes Dev 19:2187-2198.
26. Odemis V, E Lamp, G Pezeshki, B Moepps, K Schilling, P Gierschik, DR Littman and J Engele. (2005). Mice deficient in the chemokine receptor CXCR4 exhibit impaired limb innervation and myogenesis. Mol Cell Neurosci 30:494-505.
27. Odemis V, K Boosmann, MT Dieterlen and J Engele. (2007). The chemokine SDF1 controls multiple steps of myogenesis through atypical PKCzeta. J Cell Sci 120: 4050-4059.
28. Bae GU, U Gaio, YJ Yang, HJ Lee, JS Kang and RS Krauss. (2008). Regulation of myoblast motility and fusion by the CXCR4-associated sialomucin, CD164. J Biol Chem 283:8301-8309.
29. Melchionna R, A Di Carlo, R De Mori, C Cappuzzello, L Barberi, A Musaro, C Cencioni, N Fujii, H Tamamura, et al. (2010). Induction of myogenic differentiation by SDF-1 via CXCR4 and CXCR7 receptors. Muscle Nerve 41: 828-835.
30. Brzoska E, M Kowalewska, A Markowska-Zagrajek, K Kowalski, K Archacka, M Zimowska, I Grabowska, AM Czerwinska, M Czarnecka-Gora, et al. (2012). Sdf-1 (CXCL12) improves skeletal muscle regeneration via the mobilisation of Cxcr4 and CD34 expressing cells. Biol Cell 104:722-737.
31. Griffin CA, LH Apponi, KK Long and GK Pavlath. (2010). Chemokine expression and control of muscle cell migration during myogenesis. J Cell Sci 123:3052-3060.
32. Vincenti MP and CE Brinckerhoff. (2007). Signal transduction and cell-type specific regulation of matrix metalloproteinase gene expression: can MMPs be good for you? J Cell Physiol 213:355-364.
33. Schultz GS and A Wysocki. (2009). Interactions between extracellular matrix and growth factors in wound healing. Wound Repair Regen 17:153-162.
34. Mott JD and Z Werb. (2004). Regulation of matrix biology by matrix metalloproteinases. Curr Opin Cell Biol 16:558-564.
35. Huang W, T Wang, D Zhang, T Zhao, B Dai, A Ashraf, X Wang, M Xu, RW Millard, et al. (2012). Mesenchymal stem cells overexpressing CXCR4 attenuate remodeling of postmyocardial infarction by releasing matrix metalloproteinase-9. Stem Cells Dev 21:778-789.
36. Christov C, F Chretien, R Abou-Khalil, G Bassez, G Vallet, FJ Authier, Y Bassaglia, V Shinin, S Tajbakhsh, B Chazaud and RK Gherardi. (2007). Muscle satellite cells and endothelial cells: close neighbors and privileged partners. Mol Biol Cell 18:1397-1409.
37. Montero I, J Orbe, N Varo, O Beloqui, JI Monreal, JA Rodriguez, J Diez, P Libby and JA Paramo. (2006). Creactive protein induces matrix metalloproteinase-1 and-10 in human endothelial cells: implications for clinical and subclinical atherosclerosis. J Am Coll Cardiol 47:1369-1378.
38. Rodriguez JA, J Orbe, S Martinez de Lizarrondo, O Calvayrac, C Rodriguez, J Martinez-Gonzalez and JA Paramo. (2008). Metalloproteinases and atherothrombosis: MMP-10 mediates vascular remodeling promoted by inflammatory stimuli. Front Biosci 13:2916-2921.
39. Gill JH, IG Kirwan, JM Seargent, SW Martin, S Tijani, VA Anikin, AJ Mearns, MC Bibby, A Anthoney and PM Loadman. (2004). MMP-10 is overexpressed, proteolytically active, and a potential target for therapeutic intervention in human lung carcinomas. Neoplasia 6:777-785.
40. Bobadilla M, N Sainz, JA Rodriguez, G Abizanda, J Orbe, A De Martino, JM Garcia Verdugo, JA Paramo, F Prosper and A Perez-Ruiz. (2013). MMP-10 is required for efficient muscle regeneration in mouse models of injury and muscular dystrophy. Stem Cells 32:447-461.
41. De Clercq E. (2005). Potential clinical applications of the CXCR4 antagonist bicyclam AMD3100. Mini Rev Med Chem 5:805-824.
42. Zhang R, X Pan, Z Huang, GF Weber and G Zhang. (2011). Osteopontin enhances the expression and activity of MMP-2 via the SDF-1/CXCR4 axis in hepatocellular carcinoma cell lines. PLoS One 6:e23831.
43. Gong Y, Y Fan and J Hoover-Plow. (2011). Plasminogen regulates stromal cell-derived factor-1/CXCR4-mediated hematopoietic stem cell mobilization by activation of matrix metalloproteinase-9. Arterioscler Thromb Vasc Biol 31:2035-2043.
44. Bhoopathi P, C Chetty, VR Gogineni, M Gujrati, DH Dinh, JS Rao and SS Lakka. (2011). MMP-2 mediates mesenchymal stem cell tropism towards medulloblastoma tumors. Gene Ther 18:692-701.
45. Zhang H, A Trivedi, JU Lee, M Lohela, SM Lee, TM Fandel, Z Werb and LJ Noble-Haeusslein. (2011). Matrix metalloproteinase-9 and stromal cell-derived factor-1 act synergistically to support migration of blood-borne monocytes into the injured spinal cord. J Neurosci 31:15894-15903.
46. Hunger C, V Odemis and J Engele. (2012). Expression and function of the SDF-1 chemokine receptors CXCR4 and CXCR7 during mouse limb muscle development and regeneration. Exp Cell Res 318:2178-2190.
47. Misao Y, G Takemura, M Arai, T Ohno, H Onogi, T Takahashi, S Minatoguchi, T Fujiwara and H Fujiwara. (2006). Importance of recruitment of bone marrow-derived CXCR4 + cells in post-infarct cardiac repair mediated by G-CSF. Cardiovasc Res 71:455-465.
48. Saxena P, N Kejriwal and MA Newman. (2007). Use of flexible silastic drains in thoracic surgery: a word of caution. Ann Thorac Surg 83:2258-2259; author reply 2259.
49. Abbott JD, Y Huang, D Liu, R Hickey, DS Krause and FJ Giordano. (2004). Stromal cell-derived factor-1alpha plays a critical role in stem cell recruitment to the heart after myocardial infarction but is not sufficient to induce homing in the absence of injury. Circulation 110:3300-3305.
50. Dai S, F Yuan, J Mu, C Li, N Chen, S Guo, J Kingery, SD Prabhu, R Bolli and G Rokosh. (2010). Chronic AMD3100 antagonism of SDF-1alpha-CXCR4 exacerbates cardiac dysfunction and remodeling after myocardial infarction. J Mol Cell Cardiol 49:587-597.
51. Ghadge SK, S Muhlstedt, C Ozcelik and M Bader. (2010). SDF-1alpha as a therapeutic stem cell homing factor in myocardial infarction. Pharmacol Ther 129:97-108.
52. Kim DS, SI Kang, SY Lee, KT Noh and EC Kim. (2014). Involvement of SDF-1 and monocyte chemoattractant protein-1 in hydrogen peroxide-induced extracellular matrix degradation in human dental pulp cells. Int Endod J 47:298-308.
53. Naumann U, E Cameroni, M Pruenster, H Mahabaleshwar, E Raz, HG Zerwes, A Rot and M Thelen. (2010). CXCR7 functions as a scavenger for CXCL12 and CXCL11. PLoS One 5:e9175.
54. Brinckerhoff CE and LM Matrisian. (2002). Matrix metalloproteinases: a tail of a frog that became a prince. Nat Rev Mol Cell Biol 3:207-214.
55. Sachidanandan C, R Sambasivan and J Dhawan. (2002). Tristetraprolin and LPS-inducible CXC chemokine are rapidly induced in presumptive satellite cells in response to skeletal muscle injury. J Cell Sci 115:2701-2712.
56. Porter JD, W Guo, AP Merriam, S Khanna, G Cheng, X Zhou, FH Andrade, C Richmonds and HJ Kaminski. (2003). Persistent over-expression of specific CC class chemokines correlates with macrophage and T-cell recruitment in mdx skeletal muscle. Neuromuscul Disord 13:223-235.
57. Hirata A, S Masuda, T Tamura, K Kai, K Ojima, A Fukase, K Motoyoshi, K Kamakura, Y Miyagoe-Suzuki and S Takeda. (2003). Expression profiling of cytokines and related genes in regenerating skeletal muscle after cardiotoxin injection: a role for osteopontin. Am J Pathol 163:203-215.
58. Stebler J, D Spieler, K Slanchev, KA Molyneaux, U Richter, V Cojocaru, V Tarabykin, C Wylie, M Kessel and E Raz. (2004). Primordial germ cell migration in the chick and mouse embryo: the role of the chemokine SDF-1/ CXCL12. Dev Biol 272:351-361.
59. Rucci N, P Sanita and A Angelucci. (2011). Roles of metalloproteases in metastatic niche. Curr Mol Med 11:609-622.
60. Raffo D, O Pontiggia and M Simian. (2011). Role of MMPs in metastatic dissemination: implications for therapeutic advances. Curr Pharm Biotechnol 12:1937-1947.
61. McQuibban GA, JH Gong, JP Wong, JL Wallace, I Clark-Lewis and CM Overall. (2002). Matrix metalloproteinase processing of monocyte chemoattractant proteins generates CC chemokine receptor antagonists with anti-inflammatory properties in vivo. Blood 100:1160-1167.
62. Overall CM, E Tam, GA McQuibban, C Morrison, UM Wallon, HF Bigg, AE King and CR Roberts. (2000). Domain interactions in the gelatinase A.TIMP-2.MT1-MMP activation complex. The ectodomain of the 44-kDa form of membrane type-1 matrix metalloproteinase does not modulate gelatinase A activation. J Biol Chem 275:39497-39506.
63. Van Lint P and C Libert. (2007). Chemokine and cytokine processing by matrix metalloproteinases and its effect on leukocyte migration and inflammation. J Leukoc Biol 82: 1375-1381.
64. Hatfield KJ, H Reikvam and O Bruserud. (2010). The crosstalk between the matrix metalloprotease system and the chemokine network in acute myeloid leukemia. Curr Med Chem 17:4448-4461.
65. Chinni SR, S Sivalogan, ZDong, JC Filho,XDeng,RDBonfil and ML Cher. (2006). CXCL12/CXCR4 signaling activates Akt-1 andMMP-9 expression in prostate cancer cells: the role of bone microenvironment-associated CXCL12. Prostate 66:32-48.